期刊文献+

维持性血液透析患者住院相关因素分析及应对策略 被引量:1

An Analysis of Factors Related to Hospitalization of MHD Patients and Countermeasures
下载PDF
导出
摘要 目的:分析维持性血液透析(MHD)患者住院原因及相关因素,探讨减少MHD患者住院的策略。方法:对2010∽2013年某院39例MHD住院患者进行回顾性分析,并和同期非住院的MHD患者比较,观察透析次数、营养状况、血红蛋白、铁蛋白、超敏C反应蛋白、脑钠肽等指标。结果:MHD患者住院的首要原因为呼吸道感染和心功能不全;营养不良、透析充分性、透析间期体重增加过多、炎症状态、BNP增高等是MHD住院的相关因素。加强营养支持治疗和卫生宣教,及早控制潜在心功能不全及炎症状态可能会减少MHD患者住院率,改善预后。 Objective:To analyze the reasons why the MHD patients Hospitalize and relevant factors,and investigate the countermeasures to reduce the hospitalization of MHD patients.Methods:A retrospective anal-ysis was made on the data of 39 cases of hospitalized MHD patients during 2010∽2013in our hospital.Com-pare them with concurrent non-hospitalized MHD patients,detect dialysis times,nutritional status,hemoglo-bin,feeritin,high sensitivity C-reactive protein(hs-CRP),BNP and other indexes.Results:The primary cau-ses for the hospitalization of the MHD patients were respiratory infection and cardiac insufficiency;dystro-phy,dialysis adequacy,excessive weight gain during dialysis,inflammation and rising in BNP were the correl-ative factors.Conclusion:To strength nutrition-supported therapy and propaganda and education about health and try to control possible cardiac insufficiency and the inflammation earlier would lower MHD patients'hos-pitalization rate and improve prognosis.
作者 郭爱莉
出处 《数理医药学杂志》 2015年第3期378-379,共2页 Journal of Mathematical Medicine
关键词 维持性血液透析 住院 危险因素 MHD hospitalization dangerous factor
  • 相关文献

参考文献5

二级参考文献45

  • 1周文彦,倪兆慧.B型利钠肽与慢性肾脏疾病患者心血管疾病及心功能的关系[J].国外医学(泌尿系统分册),2005,25(6):871-874. 被引量:2
  • 2[1]Massry SG, Smogorzewski M. The heart in uremia. Seminars innephrology, 1996, 16(3): 214~221.
  • 3[2]Lovcic V, Sebetic D, Klobucic M, et al. [Left ventricular hy pertrophy in patient on dialysis]. Acta Med Croatica. 2003, 57(1):61~64.
  • 4[3]Nakamura S, Sasaki O, Nakahama H,et al. Left ventricular hypertrophy is a risk factor independent of hypertension in survival of hemodialyzed patients. Ren Fail, 2002, 24(2): 175~186.
  • 5[4]Mailloux LU, Bellucci AG, Wilkes BM, et al. Mortality in dialysis patients: Analysis of the causes of death. Am J Kidney Dis, 1991, 18: 326~335.
  • 6王质刚主编.血液净化学[M].北京科技出版社,1992.93-104.
  • 7Levey AS,Beto JA,Coronado BE,et al.Controlling the epidemic of cardiovasular disease in chronic renal disease:What do we know? What do we need to learn? Where do we go from here?National kidney Foundation Task Force on Cardiovascular Disease.Am J Kidney Dis,1998,32(5):853-906.
  • 8Rao M,Pereira BJ.Prospective trials on anemia of chronic disease:the trial to reduce cardiovascular events with Aranesp Therapy.Kidney Int Suppl,2003,64(87):s12-s19.
  • 9London G.Pathophysiology of cardiovascular damage in the early renal population.Nephrol Dial Transplant,2001,16(Suppl 2):3-6.
  • 10Sarnak MJ.Cardiovascular complications in chronic kidney disease.Am J Kidney Dis,2003,41 (5 Suppl):11-17.

共引文献107

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部